<DOC>
	<DOCNO>NCT01595529</DOCNO>
	<brief_summary>To determine halt antimicrobial therapy subject exhibit clinical improvement 5 day start antibiotic therapy ( short course therapy ) failure rate , define symptomatic Urinary Tract Infection ( UTI ) Test Cure ( TOC ) Day 11-14 , subject continue take antibiotic additional 5 day ( standard course therapy ) . To determine short-course therapy compare standard course therapy result similar number child gastrointestinal colonization antimicrobial resistant Escherichia coli ( E. coli ) Klebsiella pneumonia ( K. pneumoniae ) .</brief_summary>
	<brief_title>The SCOUT Study : Short Course Therapy Urinary Tract Infections Children</brief_title>
	<detailed_description>The standard-of-care treat uncomplicated UTIs 10-day course antibiotic . Some study adults show shorter course antibiotic effective treat urinary tract infection . The SCOUT Study determine five day antibiotic work well 10 day treatment child . In addition , SCOUT study determine short 5-day course antibiotic less likely contribute antibiotic resistance . The study try find reduce antibiotic course five day therapy reduce chance antimicrobial resistant bacteria develop gastrointestinal tract . Antibiotics kill sensitive bacteria strong germ may leave grow multiply . Antimicrobial resistant bacteria bacteria survive take antibiotic . If strong germ grow , antibiotic may good killing . The study compare child urinary tract infection treat 5 day antibiotic + five day placebo ( active medication ) versus treat 10 full day antibiotic therapy .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Cefixime</mesh_term>
	<mesh_term>Cephalexin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>Age randomization : least two month ( least 36 week gestational age subject &lt; two year age ) 10 year age ( 120 month ) Confirmed UTI diagnosis : I . At least one symptoms consistent diagnosis UTI include : Symptoms child ( age two month 10 year ) : fever ( documented temperature least 100.4 °F OR 38°C measure anywhere body ) dysuria Children &gt; 2 year age : suprapubic , abdominal , flank pain tenderness , urinary urgency , frequency , hesitancy Children ≥ 2 month 2 year age : poor feed vomiting AND II . Pyuria urinalysis &gt; =10 WBC/mm3 ( uncentrifuged specimen ) OR &gt; =5 WBC/hpf ( centrifuge specimen ) , OR Leukocyte esterase &gt; trace dipstick . AND III . Culture proven infection single uropathogen : &gt; =5 x 10^4 CFU/mL ( catheterize suprapubic aspiration urine specimen ) OR &gt; =10^5 CFU/mL ( clean void specimen ) . Documented Clinical Improvement Randomization Afebrile : No documented temperature equal great 100.4 °F 38°C ( measure anywhere body ) 24 hour prior enrollment visit AND Asymptomatic : report NONE follow symptom : Only child prescribe one four antibiotic placebo available eligible participate . TMPSMX Cefixime Cefdinir Cephalexin ( Note child receive onetime dose I.M . I.V . medication ( i.e . ER clinic ) prior start one four oral medication eligible enrollment ) . Parental/guardian permission ( informed consent ) appropriate , child assent ( &gt; seven year age ) . A urine culture prove infection one uropathogen least 50,000 CFU/mL collect via catheter suprapubic aspiration OR least 100,000 CFU/mL collect via clean void . A child hospitalize UTI follow : concomitant bacteremia associate UTI , urosepsis , intensive care . A child whose urine culture reveals organism resistant initially prescribe antibiotic . A child catheterassociated UTI . A child know anaphylactic allergy study product . A child phenylketonuria ( PKU ) A child diagnose congenital anomaly genitourinary tract UTI child know anatomic abnormality genitourinary tract VUR , duplicate collection system , hydronephrosis . A child able take oral medication Previous surgery genitourinary tract ( except circumcision male child ) Presence immunocompromising condition ( e.g. , HIV , malignancy , solidorgan transplant recipient , use chronic corticosteroid immunosuppressive agent ) . Unlikely complete followup ( e.g . available two followup study visit followup phone call ) A child know history type I hypersensitivity study antibiotic prescribe Enrollment another antibiotic study le 30 day prior enrollment visit . Previous enrollment individual study . Planned enrollment study coincides enrollment another therapeutic drug study ( exclude vaccine ) . A child history UTI within past 30 day A child Grade IIIV VUR A child take antibiotic prophylaxis reason . A child start Day 6 originally prescribe antibiotic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Urinary tract infection</keyword>
	<keyword>Antibiotic resistance</keyword>
	<keyword>Short course antibiotic</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Controlled clinical trial</keyword>
	<keyword>Anti Infective Agents</keyword>
	<keyword>Trimethoprim Sulfamethoxazole Combination</keyword>
	<keyword>Cefixime</keyword>
	<keyword>Cephalexin</keyword>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>Trimethoprim</keyword>
	<keyword>Sulfamethoxazole</keyword>
</DOC>